Jean-Sébastien Cleiftie
Director/Board Member at BioVex, Inc.
Jean-Sébastien Cleiftie active positions
| Companies | Position | Start | End |
|---|---|---|---|
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Director/Board Member | - | - |
Career history of Jean-Sébastien Cleiftie
Former positions of Jean-Sébastien Cleiftie
| Companies | Position | Start | End |
|---|---|---|---|
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Corporate Officer/Principal | 27/10/2016 | 01/11/2021 |
| SANOFI | Corporate Officer/Principal | 01/10/2010 | 01/08/2016 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Director/Board Member | 15/10/2009 | 24/01/2013 |
PC Associés SAS
 PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Private Equity Analyst | 01/01/2004 | 01/12/2010 |
Innoven Partners
 Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Corporate Officer/Principal | 01/02/2004 | 01/10/2010 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - | 31/08/2010 |
| KIORA PHARMACEUTICALS, INC. | Director/Board Member | - | - |
Training of Jean-Sébastien Cleiftie
| Cornell University | Masters Business Admin |
Statistics
International
| France | 6 |
| United States | 5 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Private Equity Analyst | 1 |
Sectoral
| Health Technology | 6 |
| Finance | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| SANOFI | Health Technology |
| Private companies | 7 |
|---|---|
PC Associés SAS
PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Finance |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Innoven Partners
Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Finance |
| Université de Paris 5 René Descartes | Consumer Services |
